NYB (NYB Holdings) EBITDA Margin %: 1,648.24% (As of Sep. 2025)


What is NYB Holdings EBITDA Margin %?

NYB Holdings NYB EBITDA Margin % is 1,648.24% as of Sep. 2025.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. NYB Holdings's EBITDA for the six months ended in Sep. 2025 was $1.40 Mil. NYB Holdings's Revenue for the six months ended in Sep. 2025 was $0.09 Mil. Therefore, NYB Holdings's EBITDA margin for the quarter that ended in Sep. 2025 was 1,648.24%.

NYB Holdings  (NAS:NYB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

NYB Holdings EBITDA Margin % Related Terms

NYB Holdings EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for NYB Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NYB Holdings EBITDA Margin % Chart

NYB Holdings Annual Data
Trend Sep24 Sep25
EBITDA Margin %
0.00 1,648.24

NYB Holdings Semi-Annual Data
Sep24 Sep25
EBITDA Margin % 0.00 1,648.24

NYB vs : EBITDA Margin % Comparison

For the Biotechnology subindustry, NYB Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NYB Holdings EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NYB Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where NYB Holdings's EBITDA Margin % falls into.


NYB Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

NYB Holdings's EBITDA Margin % for the fiscal year that ended in Sep. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=1.401/0.085
=1,648.24 %

NYB Holdings's EBITDA Margin % for the quarter that ended in Sep. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=1.401/0.085
=1,648.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 1,648.24% mean?
NYB Holdings (NYB) has a EBITDA Margin % of 1,648.24% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NYB Holdings and its competitors.
Is NYB Holdings' EBITDA Margin % too high?
NYB Holdings' current EBITDA Margin % is 1,648.24%.
How does NYB Holdings' EBITDA Margin % compare to ?
NYB Holdings' EBITDA Margin % of 1,648.24% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NYB Holdings and its competitors. NYB Holdings's current EBITDA Margin % is 1,648.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NYB Holdings stock overvalued right now?
NYB Holdings (NYB) has a current EBITDA Margin % of 1,648.24%. The current EBITDA Margin % is 1,648.24%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For NYB Holdings (NYB), the current EBITDA Margin % is 1,648.24% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NYB Holdings Business Description

Comparable Companies
Address 456 Alexandra Road, No. 04-07, Fragrance Empire Building, Singapore, SGP, 119962
NYB Holdings Ltd, along with its subsidiaries, is a pre-clinical biopharmaceutical company engaged in the research and development of therapeutics and nutraceuticals derived from biodiversity, including tropical medicinal plants with a history of traditional use. It focuses on discovering and developing natural compounds for applications in oncology and other chronic diseases, and also offers a consumer nutraceutical product line.